Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael W. Dunne currently holds 241,001 shares of Durata Therapeutics, Inc. (DRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael W. Dunne has been a net buyer of DRTX stock. They have purchased $177.4K and sold $57.3K worth of shares.
Michael W. Dunne's most recent insider trade was on Nov 18, 2025, when they purchased 6,000 shares at $0.37 per share.
Michael W. Dunne serves as Executive at Durata Therapeutics, Inc. (DRTX). They have executed 31 insider transactions totaling $234.8K over their tenure at the company.
Michael W. Dunne holds the position of Executive at Durata Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Michael W. Dunne has shown a buying trading pattern, with $177.4K in total purchases and $57.3K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael W. Dunne was on Jan 26, 2021, when they sold $57.3K worth of ITRM shares. This transaction involved 33,143 shares at $1.73 per share.
Michael W. Dunne currently owns 241,001 shares of Durata Therapeutics, Inc. (DRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael W. Dunne's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael W. Dunne has 31 Form 4 filings on record as an insider at Durata Therapeutics, Inc..
Set alerts for Michael W. Dunne and 40,000+ other insiders.